- Podcast Series
- Targeted Therapies in Lung Cancer 2023
- ASCO® 2023
- Lung Cancer OncTalk
- Blood Cancer OncTalk
- 2022 Melanoma Video Library
- OncTalk 2022
- ASCO Lung Review 2022
- ASCO and ESMO Lung Recap
- 2021 Targeted Therapies Patient Forum
- COVID-19
- Lung
- Hematologic Oncology
- Head and Neck
- Brain
- Palliative
- Genitourinary
- General
- Breast
Playback speed
10 seconds
ASCO/ESMO Update on Locally Advanced HNSCC: Does the anti-PD1 Pembro Concomitant With RT Improve Carcinologic Outcomes vs. SOC Cetuximab-RT?
0 views
January 30, 2021
Comments 0
Login to view comments.
Click here to Login
Head and Neck